Lumentum Announces Upcoming Investor Events
Get Alerts LITE Hot Sheet
Join SI Premium – FREE
SAN JOSE, Calif., Aug. 22, 2022 /PRNewswire/ -- Lumentum Holdings Inc. ("Lumentum") today announced that company management is currently scheduled to participate in the following investor events:
Event: | Jefferies Semis, IT Hardware & Comms Infrastructure Summit 2022 |
Date: | Tuesday, August 30, 2022 |
Meeting Availability: | 8:45 a.m. – 4:10 p.m. Central Time |
Event: | Goldman Sachs Communacopia & Technology Conference |
Date: | Monday, September 12, 2022 |
Webcast Link: | https://event.webcasts.com/viewer/event.jsp?ei=1566369&tp_key=697ccc6dbc |
Presentation Time: | 9:15 a.m. Pacific Time |
Institutional investors interested in participating in these events should contact their representative at these firms.
About Lumentum
Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in San Jose, California with R&D, manufacturing, and sales offices worldwide. For more information, visit www.lumentum.com and follow Lumentum on LinkedIn, Twitter, Facebook, Instagram and YouTube.
Contacts:Investors: Kathy Ta, 408-750-3853; [email protected]
Media: Sean Ogarrio, 408-546-5405; [email protected]
Category: Financial
View original content:https://www.prnewswire.com/news-releases/lumentum-announces-upcoming-investor-events-301610165.html
SOURCE Lumentum
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shui On Land Named Among TIME's World's Most Impactful Companies 2026
- Best Ways to Dispose of Needles at Home Safely (2026): Sharps Assure Recognized by Consumer365
- Mezzion Reports Positive In Vivo Results for Udenafil in ADPKD
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share